Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GeneDx Holdings Corp.

GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14th, 2023
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx Rare Disease Data Demonstrates Utility in Drug Candidate Identification for Common Diseases
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx Announces Closing of Underwritten Public Offering and Concurrent Registered Direct Offering
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx Holdings Announces Pricing Of A $150 Million Underwritten Public Offering Of Class A Common Stock And Concurrent Registered Direct Offering
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
GeneDx Announces Proposed Underwritten Public Offering of Class a Common Stock and Concurrent Registered Direct Offering
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers WGS
Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance
From GeneDx Holdings Corp.
Via Globe NewsWire
Tickers SMFR SMFRW
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.